No Picture
News

Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

FREMONT, Calif. and WALTHAM, Mass.: FREMONT, Calif. and WALTHAM, Mass., July 29, 2021 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class me… […]

No Picture
News

FDA’s oncology head Rick Pazdur defends the accelerated approval pathway, claiming it is ‘under attack’

The FDA is sounding the alarm over its accelerated approval pathway as backlash continues over the recent nod in favor of Biogen’s Alzheimer’s drug Aduhelm, and an ODAC meeting on six such approvals that could potentially be pulled from the market — tw… […]

No Picture
News

SLAC partners with national labs and scientific publishing organizations on transgender-inclusive name-change process for published papers

The process, which also facilitates name changes for religious, marital and other reasons, allows researchers of all genders to own their academic work by updating their names on previous publications. […]

No Picture
News

CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

SOUTH SAN FRANCISCO, Calif., July 29, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated therapeutics based … […]

No Picture
News

Crohn’s Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30

LAS VEGAS: LAS VEGAS, July 29, 2021 /PRNewswire/ — DelveInsight’s Crohn’s Disease (CD) Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Crohn’s Disease market share of the individual therapies, current an… […]

No Picture
News

Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion

DUBLIN: DUBLIN, July 29, 2021 /PRNewswire/ — The "Drug Delivery Systems (DDS) Global Market – Forecast To 2027" report has been added to ResearchAndMarkets.com’s offering. Global drug delivery systems market is expected to reach $158,006.4 m… […]

No Picture
News

Roche nabs priority review for Eylea competitor; Italy’s Angelini eyes CNS, rare disease startups with $35M Lumira fund

The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific antibody designed for the eye. Roche announced late Wednesday that its application for faricimab has been ac… […]

No Picture
News

Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate

CAMBRIDGE, Mass. & MENLO PARK, Calif.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceu… […]